Kayla Zamborsky

机构：University Hospitals of Cleveland

发表论文 7 篇 · 总被引 262 次 · h-index 4

代表论文

Prophylactic Tocilizumab Prior to Anti-CD19 CAR-T Cell Therapy for Non-Hodgkin Lymphoma (2021 · Frontiers in Immunology · 被引 119)
Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma (2020 · Frontiers in Immunology · 被引 101)
A Phase I Study to Determine the Maximum Tolerated Dose of ex Vivo Expanded Natural Killer Cells Derived from Unrelated, HLA-Disparate Adult Donors (2022 · Transplantation and Cellular Therapy · 被引 32)
Treatment of non-Hodgkin lymphoma with point-of-care manufactured CAR T cells: a dual institution, phase 1 trial (2025 · EClinicalMedicine · 被引 7)
Effective gmp-compliant point of care manufacturing of anticd19 chimeric antigen receptor t cells for non hodgkin lymphoma patients using the clinimacs prodigy® (2020 · Cytotherapy · 被引 3)
Final Results of a Phase 1 Study of AntiCD19 CAR-T Cells with TNFRSF19 Transmembrane Domain (2021 · Blood)